Ismail Yigitbasi

Ismail Yigitbasi

Auto-generated profile, based on publicly available information

Ismail Yigitbasi

University of Health Sciences, Turkey

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Urology Research and Practice
Verified
Journal Article
Closed access
SŞSelçuk Şahin
Selçuk Şahin
MYMustafa Gürkan Yenice
Mustafa Gürkan Yenice
VTVolkan Tuğcu
Volkan Tuğcu
OAOktay Akça
Oktay Akça
AŞAbdulmuttalip Şimşek
Abdulmuttalip Şimşek
ATAli İhsan Taşçı
Ali İhsan Taşçı
Objective: We compared the outcomes of robotic-assisted radical perineal prostatectomy (r-PRP) versus robotic-assisted transperitoneal laparoscopic radical prostatectomy (RARP). Material and methods: Between November 2016 and September 2017 in our center, 40 patients underwent r-PRP, and 40 patients underwent RARP. All patients also underwent multiparametric magnetic resonance imaging (mpMRI) to exclude the cases with locally advanced disease. Patients with localized prostate cancer (C–T2N0M0) were included in the study. The exclusion criteria were contraindications for undergoing robotic radical prostatectomy; the Gleason score ≥4+3; extracapsular extension proven on biopsy or suspected on mpMRI; clinical stage ≥T2c; required pelvic lymph dissection according to Partin’s normogram; previous radiation therapy; hormonal therapy; any previous prostatic, urethral, or bladder neck surgery; and preoperative urinary incontinence or erectile dysfunction. Patients were placed in the exaggerated lithotomy position with 15° Trendelenburg for r-PRP and 40° Trendelenburg for RARP. Results: The mean age for the r-PRP and RARP groups were 61.2 (46–73) and 62.2 (50–75) years, respectively. The mean body mass index was significantly higher in the r-PRP group (p=0.02). The mean procedure duration time was 169.4 (100–255) minutes for the r-PRP group and 173.1 (130–210) minutes for the RARP group. The mean console time and anastomosis time were significantly lower for the r-PRP group. The mean estimated blood loss was significantly lower for the r-PRP group (p=0.002). Immediate continence rates in the r-PRP and RARP groups following the urethral catheter removal were 42% and 35% (p=0.30), respectively. Continence rates increased to 94.2% in the r-PRP and 72% in RARP (p=0.001) group at the 6th month, and to 95% in the r-PRP and 85.2% in RARP (p=0.02) group at the 9th month follow-up period. According to the International Index of Erectile Function-5 (IIEF-5), the erectile function rates at the 3-, 6-, and 9-month follow-up in the r-PRP group were 44%, 66%, and 75%, respectively. The rates in the RARP group at the 3-, 6-, and 9-month follow-up were 25%, 42%, and 66% (p=0.001), respectively. Conclusion: In our experience, r-PRP has acceptable morbidity, excellent surgical and pathological outcomes, and satisfactory oncologic and functional results compared to RARP. Cite this article as: Tuğcu V, Akça O, Şimşek A, Yiğitbaşı İ, Şahin S, Yenice MG, et al. Robotic-assisted perineal versus transperitoneal radical prostatectomy: A matched-pair analysis. Turk J Urol 2019; 45(4): 265-72.

1 May 2018 in Journal of Endourology Case Reports
Verified
Journal Article
Open access
VTVolkan Tugcu
Volkan Tugcu
ASAbdulmuttalip Simsek
Abdulmuttalip Simsek
IYIsmail Yigitbasi
Ismail Yigitbasi
MYMustafa Gurkan Yenice
Mustafa Gurkan Yenice
SSSelcuk Sahin
Selcuk Sahin
ATAli Ihsan Tasci
Ali Ihsan Tasci
Background: After almost two decades, transabdominal robotic radical prostatectomy techniques have been fully developed and are widely practiced by many robotic urologists. Recently, a transperineal robotic radical prostatectomy, a technique not yet popular to many, was introduced as an alternative approach in patients with previous abdominal surgery. Here, we present our unique experience with robotic perineal radical prostatectomy (r-PRP) on a kidney transplant recipient. Case Presentation: A 71-year-old man who had a kidney transplant 4 months previously was diagnosed with prostate cancer (PCa) and underwent r-PRP using the da Vinci Xi robotic system. The operative time was 110 minutes and blood loss was minimal. After the perineal drain was removed on postoperative day 3, the patient was discharged. The urethral catheter was subsequently removed on postoperative day 8. Pathologic analysis revealed localized PCa with negative surgical margins. Conclusion: The r-PRP offers all the advantages of minimally invasive surgery. Moreover, in a kidney transplant recipient, it provides additional benefits, such as avoidance of allograft vascular and ureteral injuries, while maintaining an equivalent oncologic efficacy and surgical safety compared with its transabdominal counterpart.

1 June 2020 in International braz j urol
Verified
Journal Article
Open access
PDF file
MYMustafa Gurkan Yenice
Mustafa Gurkan Yenice
IYIsmail Yigitbasi
Ismail Yigitbasi
RTRustu Turkay
Rustu Turkay
SSSelcuk Sahin
Selcuk Sahin
VTVolkan Tugcu
Volkan Tugcu
Minimally invasive techniques are used increasingly by virtue of advancements in technology. Surgery for prostate cancer, which has high morbidity, is performed with an increasing momentum based on the successful oncological and functional outcomes as well as cosmetic aspects. 62 patients underwent robot-assisted perineal radical prostatectomy (R-PRP) surgery at our clinic between November 2016 and August 2017. Six pelvimetric dimensions were defined and measured by performing multiparametric magnetic resonance imaging (mpMRI) prior to operation in all patients. In light of these data, we aimed to investigate the effect of pelvimetric measurements on surgery duration and surgical margin positivity. By using this technique in pelvic area, we observed that measurements only representing surgical site and excluding other pelvic organs had a significant effect on surgery duration, and pelvic dimensions had no significant effect on surgical margin positivity. In R-PRP technique, peroperative findings and oncological outcomes can vary depending on several variable factors, but although usually not taken into account, pelvimetric measurements can also affect these outcomes. However, there is a need for randomised controlled trials to be conducted with more patients.

1 December 2018 in Üroonkoloji Bülteni
Verified
Journal Article
Closed access
KSKamil Gokhan Seker
Kamil Gokhan Seker
EŞEmre Şam
Emre Şam
OÖOsman Özdemir
Osman Özdemir
İYİsmail Yiğitbaşı
İsmail Yiğitbaşı
IEİsMail Evren
İsMail Evren
VTVolkan Tuğcu
Volkan Tuğcu